Cleo key facts
as of Oct 2026- Developer of a holistic family benefits platform designed for employee wellness and healthcare cost containment.
- Cleo is valued at approximately $220.0M as of Oct 2026 (last reported valuation).
- It has raised $84.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Gaingels, New Enterprise Associates, Felicis, Greylock, Foundation Capital — 23 tracked in total.
- Status: Privately Held (backing).
Cleo's last reported valuation, Mar 2021. Nothing priced has surfaced since.
- ·The complete investor list: 23 names
- ·Watch Cleo: the Monday email on marks, rounds and moves
Cleo funding rounds
No funding rounds for Cleo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Cleo
23+Cleo valuation
Cleo's last reported valuation was $220 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.
Cleo investors
23 investors are on record for Cleo, including Gaingels, New Enterprise Associates, Felicis and Greylock. By type, the record holds 11 venture capital firms and 1 growth equity firm.
About Cleo
Developer of a holistic family benefits platform designed for employee wellness and healthcare cost containment. The company's platform integrates a global network of certified care practitioners with an artificial intelligence-driven analytical suite to provide personalized coaching and concierge services, enabling enterprise employers and health plans to improve employee retention and mental health outcomes while reducing overall medical spend.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 254
- Website
- hicleo.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.